NCT02925754

Brief Summary

Pain catastrophizing is conceptualized as a negative cognitive-affective response to anticipated or actual pain and has been associated with a number of important pain-related outcomes. The aims of this study are

  1. 1.To describe the characteristics of the patients and determinants of catastrophizing in chronic painful patients hospitalized in rheumatology in the Nîmes University Hospital
  2. 2.To describe the impact of the catastrophizing on the level of insomnia and the drugs consumption in chronic painful patients hospitalized in rheumatology in the Nîmes University Hospital

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 16, 2016

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 6, 2016

Completed
Last Updated

October 6, 2016

Status Verified

September 1, 2016

Enrollment Period

8 months

First QC Date

September 16, 2016

Last Update Submit

October 5, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Catastrophizing Scale

    Day 0

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

adults hospitalized in the department of rheumatology of the Nîmes University Hospital with chronic pain (≥ 6 months)

You may qualify if:

  • adults hospitalized in the department of rheumatology of the Nîmes University Hospital with chronic pain (≥ 6 months)

You may not qualify if:

  • benzodiazepine or neuroleptic use for epilepsia, alcool, psychiatric disorders
  • Restless Legs syndrom
  • Obstructive Sleep Apnea
  • narcolepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2016

First Posted

October 6, 2016

Study Start

August 1, 2015

Primary Completion

April 1, 2016

Last Updated

October 6, 2016

Record last verified: 2016-09